Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jeffrey M Sivik"'
Autor:
Hong Zheng, Raymond J. Hohl, Joseph J. Drabick, Todd D. Schell, Jeffrey M. Sivik, Michael G. Bayerl, Hiroko Shike, Ming Wang, Shin Mineishi, Witold B. Rybka, W. Christopher Ehmann, David F. Claxton, Kevin L. Rakszawski, Chenchen Zhao, Bei Jia
Acute myeloid leukemia (AML) is a devastating blood cancer with poor prognosis. Immunotherapy targeting inhibitory pathways to unleash the antileukemia T-cell response is a promising strategy for the treatment of leukemia, but we must first understan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f54e2c0605cbce37fa780762b3e51b9
https://doi.org/10.1158/0008-5472.c.6511385.v1
https://doi.org/10.1158/0008-5472.c.6511385.v1
Autor:
Hong Zheng, Raymond J. Hohl, Joseph J. Drabick, Todd D. Schell, Jeffrey M. Sivik, Michael G. Bayerl, Hiroko Shike, Ming Wang, Shin Mineishi, Witold B. Rybka, W. Christopher Ehmann, David F. Claxton, Kevin L. Rakszawski, Chenchen Zhao, Bei Jia
Supplemental Table 1: Analysis of potential confounding factors; Supplemental Table 2: Multivariate Cox proportional hazard analysis; Supplemental Figure 1: The expression of CXCR5 and TCF1; Supplemental Figure 2: Comparing Fraction III CD8 T cells v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::142290b5096f7d7f7aa7247fed58db63
https://doi.org/10.1158/0008-5472.22422962.v1
https://doi.org/10.1158/0008-5472.22422962.v1
Autor:
Kathleen M. Kokolus, Ying Zhang, Jeffrey M. Sivik, Carla Schmeck, Junjia Zhu, Elizabeth A. Repasky, Joseph J. Drabick, Todd. D. Schell
Publikováno v:
OncoImmunology, Vol 7, Iss 3 (2018)
Immunotherapy has expanded treatment options for cancers with historically poor outcomes, yet a significant proportion of patients still fail to achieve durable clinical benefit. We defined the contribution of β-adrenergic receptor (βAR) signaling,
Externí odkaz:
https://doaj.org/article/90d50fbec4db4ddb895962259343db4e
Autor:
Emma Zulch, Nicholas Streck, Joseph Matthew Cioccio, Kevin L Rakszawski, Myles Nickolich, W. Christopher Ehmann, Baldeep Wirk, Seema G Naik, Witold B. Rybka, Hong Zheng, Jeffrey M Sivik, Cory Hale, Joseph Mierski, Brooke Silar, Robert Greiner, Valerie Brown, Hiroko Shike, David F. Claxton, David Craft, April Bobenchik, Shin Mineishi, Catharine I Paules, Kentaro Minagawa
Publikováno v:
Blood. 140:7589-7590
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37899a210b70d19199248161b8e79d71
https://doi.org/10.1182/blood-2022-167227
https://doi.org/10.1182/blood-2022-167227
Autor:
Bei, Jia, Chenchen, Zhao, Kevin L, Rakszawski, David F, Claxton, W Christopher, Ehmann, Witold B, Rybka, Shin, Mineishi, Ming, Wang, Hiroko, Shike, Michael G, Bayerl, Jeffrey M, Sivik, Todd D, Schell, Joseph J, Drabick, Raymond J, Hohl, Hong, Zheng
Publikováno v:
Cancer research. 79(7)
Acute myeloid leukemia (AML) is a devastating blood cancer with poor prognosis. Immunotherapy targeting inhibitory pathways to unleash the antileukemia T-cell response is a promising strategy for the treatment of leukemia, but we must first understan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e874e0953e67e98d56c963dd85c845d
https://pubmed.ncbi.nlm.nih.gov/30709927
https://pubmed.ncbi.nlm.nih.gov/30709927